Research centers around the world are throwing everything and anything at the global pandemic, in a desperate attempt to slow it down. Seemingly everything is on the table, from the outrageous suggestions like bleach to the scientifically backed options, such as dexamethasone. Somewhere in this midst of this frantic experimentation is a new discussion about COVID and cannabis.
Unlike some of the more ridiculous (and downright dangerous) options circulating for the treatment of COVID-19, cannabis has some compelling scientific evidence. One of the newest pieces of information is coming from Eybna and CannaSoul Analytics, two Israeli based research and development companies. In particular, they are exploring cannabidiol (CBD) and a suite of anti-inflammatory terpenes.
CBD and Terpenes to Fight COVID-19
As reported by Forbes, the Israeli research partnership led by Associate Professor Dedi Meiri compared CBD, a trademarked terpene formulation, and one of the leading COVID-19 treatments, dexamethasone. Dexamethasone is a common steroid for effects on cytokine secretion. The study’s goal was to determine if either of the cannabis extracts (CBD or terpenes) had an impact on the development of dangerous cytokine storms.
Read more at rxleaf.com